Induction of a late asthmatic response associated with airway inflammation in mice.
To investigate mechanisms underlying the late asthmatic response, we developed a murine model using repetitive intratracheal antigen challenge. BALB/c mice sensitized by i.p. injection with ovalbumin+alum were challenged with ovalbumin intratracheally 4 times. The 1st challenge induced early airway obstruction peaking at 30 min but without a late response; however, the 4th challenge caused not only early but also late airway obstruction at 2-8 h. Eosinophils, and CD4+ and CD8+ T lymphocytes were increased in the airway before the 4th but not before the 1st-3rd challenges. The numbers of IgE+/CD117+ (mast) cells were also increased in the lung before the 4th challenge. Levels of Th2 cytokines were also increased in the airway. Daily administration of dexamethasone during the challenge period suppressed all these inflammatory events. Thus, this experimental late asthmatic response is associated with Th2 cytokine production from inflammatory cells recruited as a consequence of the 1st-3rd challenges.
Nabe
Takeshi
T
Department of Microbiology, University of Alabama at Birmingham, 859 Bevill Biomedical Research Building, 845 19th Street South, Birmingham, AL 35294-2170, USA.
Zindl
Carlene L
CL
Jung
Yong Woo
YW
Stephens
Robin
R
Sakamoto
Akari
A
Kohno
Shigekatsu
S
Atkinson
T Prescott
TP
Chaplin
David D
DD
D000402:Airway Obstruction / Q000150:complications* / Q000276:immunology / Q000517:prevention & control; D000403:Airway Resistance / Q000276:immunology; D000534:Alum Compounds / Q000008:administration & dosage; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001249:Asthma / Q000209:etiology* / Q000276:immunology / Q000517:prevention & control; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000166:cytology / Q000276:immunology; D054413:Chemokine CCL11; D019742:Chemokines, CC / Q000032:analysis; D016207:Cytokines / Q000032:analysis; D003907:Dexamethasone / Q000494:pharmacology; D004195:Disease Models, Animal; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D007073:Immunoglobulin E / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology; D007249:Inflammation / Q000150:complications* / Q000276:immunology / Q000517:prevention & control; D007274:Injections, Intraperitoneal; D007962:Leukocytes / Q000187:drug effects / Q000276:immunology; D008168:Lung / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D008407:Mast Cells / Q000187:drug effects / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D010047:Ovalbumin / Q000008:administration & dosage / Q000276:immunology; D019009:Proto-Oncogene Proteins c-kit / Q000276:immunology; D013997:Time Factors
D000534:Alum Compounds; D000893:Anti-Inflammatory Agents; C515457:Ccl11 protein, mouse; D054413:Chemokine CCL11; D019742:Chemokines, CC; D016207:Cytokines; D007074:Immunoglobulin G; C446402:ovalbumin-alum; D007073:Immunoglobulin E; D003907:Dexamethasone; D010047:Ovalbumin; D019009:Proto-Oncogene Proteins c-kit